Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 28,759 | 29,975 | 28,427 | 26,922 | 29,208 |
| Cost of Goods | 12,086 | 11,629 | 12,594 | 14,750 | 12,571 |
| Gross Profit | 16,673 | 18,346 | 15,833 | 12,172 | 16,637 |
| Operating Expenses | 15,963 | 17,226 | 16,884 | 16,684 | 13,210 |
| Operating Income | 796 | 1,749 | -457 | -3,762 | 3,998 |
| Interest Expense | 941 | 974 | 900 | 749 | 515 |
| Other Income | -1,953 | 432 | 465 | -179 | -62 |
| Pre-tax Income | -2,098 | 1,207 | -892 | -4,690 | 3,421 |
| Income Tax | -1,118 | 585 | 774 | -1,285 | 986 |
| Net Income Continuous | -980 | 622 | -1,666 | -3,405 | 2,435 |
| Net Income | $-980 | $622 | $-1,666 | $-3,405 | $2,435 |
| EPS Basic Total Ops | -0.20 | 0.10 | -0.40 | -0.80 | 0.60 |
| EPS Basic Continuous Ops | -0.23 | 0.15 | -0.40 | -0.82 | 0.59 |
| EPS Diluted Total Ops | -0.20 | 0.10 | -0.40 | -0.80 | 0.60 |
| EPS Diluted Continuous Ops | -0.23 | 0.15 | -0.38 | -0.82 | 0.57 |
| EBITDA(a) | $2,587 | $3,540 | $1,574 | $-1,756 | $5,898 |